Key opinion leaders highlight barriers to MDR HIV treatment adherence. Ryan Haumschild, PharmD, MS, MBA: What are the implications of nonadherence to standard background therapy while taking a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback